Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04334967Phase 4Suspended
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
2019 Novel Coronavirus2019-nCoVCorona Virus Infection+2 more
PrincipalinvestigatorStart date: 2020-03-30

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Providence Medical Group Infectious Disease

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04334967Phase 4PrincipalInvestigator

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

2019 Novel Coronavirus2019-nCoVCorona Virus Infection+2 more
Suspended

All 1 trials loaded